Author

Na Li

Institution: Shaanxi University of Science and Technology

Observed institutions: Wuhan Polytechnic University, Shaanxi University of Science and Technology

ORCID: 0000-0001-5930-412X

Observed ORCID: 0000-0001-5930-412X

OpenAlex ID: A5028312727

Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

2022 · Yifan Zhai, Qiuqiong Tang, et al. · Clinical Cancer Research · 20

Vision-Based Multi-Scale Structural Modeling of Water Loss during Morchella Drying

2026 · Xuchao Feng, Hongbo Li, et al. · Journal of Future Foods

Supplementary Table S1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

2025 · Yifan Zhai, Qiuqiong Tang, et al.

Supplementary Appendix 1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

2025 · Yifan Zhai, Qiuqiong Tang, et al.

Supplementary Figures S1-S5 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

2025 · Yifan Zhai, Qiuqiong Tang, et al.

Dihydromyricetin microcapsule preparation and effect on renal function and gastric mucosa in type 2 diabetic mice

2025 · Hu Wang, Shun Wang, et al. · Journal of Future Foods

Supplementary Appendix 1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

2023 · Yifan Zhai, Qiuqiong Tang, et al.

Supplementary Figures S1-S5 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

2023 · Yifan Zhai, Qiuqiong Tang, et al.

Supplementary Table S1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

2023 · Yifan Zhai, Qiuqiong Tang, et al.

Data from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

2023 · Yifan Zhai, Qiuqiong Tang, et al.

Data from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

2023 · Yifan Zhai, Qiuqiong Tang, et al.

Works count: 11

Citation count: 20

H-index: 1

I10-index: 1